Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 29, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - May 29, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/29/17 - "Nano- and Micro-Sized Particles of 20-Camptothecin Or Derivative Thereof and Pharmaceutical Compositions Containing Same, and Treatment of Cancers...
"Nano- and Micro-Sized Particles of 20- Camptothecin Or Derivative Thereof and Pharmaceutical Compositions Containing Same, and Treatment of Cancers Therewith" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Cancer Gene Therapy Week A patent application by the inventors CHEN, Wenhao; ZHANG, Jiyao; CAO, Zhisong, fil
5/29/17 - "Oral Administration of Melanin for Protection against Radiation" in Patent Application Approval Process (USPTO 20170128416)
By a News Reporter-Staff News Editor at Bioterrorism Week A patent application by the inventors Dadachova, Ekaterina; Casadevall, Arturo, filed on August 8, 2016, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Albert Einstei
5/29/17 - "Rapidly Disintegrating Films for Delivery of Pharmaceutical Or Cosmetic Agents" in Patent Application Approval Process (USPTO 20170128358)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BARNHART, Scott D.; FULL, Andrew P.; MORITZ, Cathy M., filed on January 24, 2017, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not bee
5/29/17 - "Stable Pharmaceutical Composition and Methods of Using Same" in Patent Application Approval Process (USPTO 20170128402)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, filed on January 25, 2017, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent ap
5/29/17 - "Sustained Release Pharmaceutical Compositions and Methods of Use" in Patent Application Approval Process (USPTO 20170128424)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor ROTHSTEIN, Sam, filed on November 11, 2016, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution.
5/29/17 - Acerus Reports First Quarter 2017 Financial Results
By a News Reporter-Staff News Editor at Pharma Business Week Acerus Pharmaceuticals Corporation reported its financial results for the three month period ended March 31, 2017. Unless otherwise noted, all amounts are in U.S. dollars. "The Canadian launch of Natesto is off to a very strong start and prescriptions in the U.S. have been accelerat
5/29/17 - Actinium Pharmaceuticals, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (May. 15, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Actinium Pharmaceuticals, Inc. was posted on May 15, 2017. The SEC file number is 0001213900-17-005183.. A U.S. Securities and Exchange Commission fi
5/29/17 - Actinium Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report (May. 11, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Actinium Pharmaceuticals, Inc. was posted on May 11, 2017. The SEC file number is 0001213900-17-004962.. A U.S. Securities and Exchange Commission fi
5/29/17 - Actinium Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report (May. 16, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Actinium Pharmaceuticals, Inc. was posted on May 16, 2017. The SEC file number is 0001213900-17-005355.. A U.S. Securities and Exchange Commission fi
5/29/17 - Acura Pharmaceuticals, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (May. 12, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on May 12, 2017. The SEC file number is 0001144204-17-026909.. A U.S. Securities and Exchange Commission filin
5/29/17 - Acura Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report (May. 12, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on May 12, 2017. The SEC file number is 0001144204-17-026907.. A U.S. Securities and Exchange Commission filin
5/29/17 - Adamas Pharmaceuticals Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)] (May. 11, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on May 11, 2017. The SEC file number is 0001047469-17-003343.. A U.S. Securities and Exchange Commission filin
5/29/17 - Adamas Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (May. 11, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on May 11, 2017. The SEC file number is 0001104659-17-031764.. A U.S. Securities and Exchange Commission filin
5/29/17 - Aeolus Pharmaceuticals, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (May. 15, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeolus Pharmaceuticals, Inc. was posted on May 15, 2017. The SEC file number is 0001654954-17-004754.. A U.S. Securities and Exchange Commission fili
5/29/17 - Agile Therapeutics Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (May. 12, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agile Therapeutics Inc. was posted on May 12, 2017. The SEC file number is 0001104659-17-032097.. A U.S. Securities and Exchange Commission filing is
5/29/17 - Aileron Therapeutics Announces Oral Presentation at ASCO on ALRN-6924 Targeting p53
By a News Reporter-Staff News Editor at Clinical Trials Week Aileron Therapeutics, a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, announced that the Company's abstract for ALRN-6924, its lead stapled peptide product candidate targeting p53, was selected for an oral presentation at the 2
5/29/17 - Akorn Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (May. 15, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Akorn Inc. was posted on May 15, 2017. The SEC file number is 0001171843-17-003099.. A U.S. Securities and Exchange Commission filing is a formal doc
5/29/17 - Akorn Inc. Files SEC Form 4/A, Statement of Changes in Beneficial Ownership of Securities (May. 15, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Akorn Inc. was posted on May 15, 2017. The SEC file number is 0001171843-17-003100.. A U.S. Securities and Exchange Commission filing is a formal doc
5/29/17 - Alexion Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (May. 12, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on May 12, 2017. The SEC file number is 0001638599-17-000441.. A U.S. Securities and Exchange Commission fili
5/29/17 - Alexion Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (May. 12, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on May 12, 2017. The SEC file number is 0000899866-17-000099.. A U.S. Securities and Exchange Commission fili
5/29/17 - Alexion Pharmaceuticals Inc. Files SEC Form S-8 POS, Securities To Be Offered To Employees in Employee Benefit Plans, Post-effective Amendments (May....
Alexion Pharmaceuticals Inc. Files SEC Form S-8 POS, Securities To Be Offered To Employees in Employee Benefit Plans, Post-effective Amendments. By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alex
5/29/17 - Alexion Pharmaceuticals Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (May. 11, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on May 11, 2017. The SEC file number is 0000899866-17-000086.. A U.S. Securities and Exchange Commission fili
5/29/17 - Alimera Sciences Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (May. 11, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alimera Sciences Inc. was posted on May 11, 2017. The SEC file number is 0001267602-17-000037.. A U.S. Securities and Exchange Commission filing is a
5/29/17 - Allergan Plc Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (May. 16, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on May 16, 2017. The SEC file number is 0001179110-17-007360.. A U.S. Securities and Exchange Commission filing is a formal d
5/29/17 - Allergan Plc Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (May. 16, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on May 16, 2017. The SEC file number is 0001179110-17-007335.. A U.S. Securities and Exchange Commission filing is a formal d
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415